A detailed history of Perceptive Advisors LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 2,319,646 shares of EWTX stock, worth $41.8 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
2,319,646
Previous 555,555 317.54%
Holding current value
$41.8 Million
Previous $6.08 Million 596.23%
% of portfolio
0.89%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.25 - $19.97 $16.3 Million - $35.2 Million
1,764,091 Added 317.54%
2,319,646 $42.3 Million
Q4 2023

Feb 14, 2024

BUY
$5.51 - $12.1 $3.06 Million - $6.72 Million
555,555 New
555,555 $6.08 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.14B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.